Related Experiment Video

Updated: Jul 18, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

Features and prognoses of infantile patients with atopic dermatitis hospitalized for severe complications

Norito Katoh1, Hajime Hosoi, Tohru Sugimoto

  • 1Department of Dermatology, Kyoto Prefectural University of Medicine Graduatw School of Medical Science, Kamigyo-ku, Kyoto, Japan. nkatoh@koto.kpu-m.ac.jp

The Journal of Dermatology
|December 16, 2006
PubMed

Insights

Severe infantile atopic dermatitis (AD) can cause serious systemic complications. However, prompt treatment with topical corticosteroids leads to remarkable improvement and favorable long-term outcomes for affected infants.

Area of Science:

  • Dermatology
  • Pediatrics
  • Internal Medicine

Background:

  • Atopic dermatitis (AD) in infants, though typically non-life-threatening, can rarely present with severe systemic complications.
  • These complications can include hypoproteinemia, hypovolemia, thrombocytosis, reduced immunoglobulin G, elevated liver enzymes, and growth retardation.

Purpose of the Study:

  • To describe the clinical presentation and outcomes of infants with severe systemic complications secondary to atopic dermatitis.
  • To evaluate the efficacy of topical corticosteroid treatment in managing severe infantile AD and its associated complications.

Main Methods:

  • Case series describing six infants hospitalized with severe, widespread dermatitis and systemic complications.
  • Treatment involved topical corticosteroids; clinical data and disease course were monitored during hospitalization and follow-up.

Main Results:

  • Patients presented with severe AD and complications including hypoproteinemia, hypovolemia, thrombocytosis, low IgG, elevated liver enzymes, and growth retardation.
  • Topical corticosteroid treatment resulted in significant improvement of dermatitis within a median of 20 days.
  • Abnormal clinical laboratory values normalized by discharge, and long-term follow-up showed stable skin condition and absence of systemic issues with appropriate management.

Conclusions:

  • Severe infantile atopic dermatitis can be associated with potentially life-threatening systemic complications.
  • Early and adequate treatment with topical corticosteroids offers a favorable prognosis for both the skin condition and systemic issues in infants with severe AD.

More Related Videos

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: